Ethyl pyruvate administration inhibits hepatic tumor growth.
about
Emerging roles for HMGB1 protein in immunity, inflammation, and cancerEthyl pyruvate is a novel anti-inflammatory agent to treat multiple inflammatory organ injuriesEthyl Pyruvate Combats Human Leukemia Cells but Spares Normal Blood CellsHMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma.High-mobility group box 1 and cancer.Emerging role of HMGB1 in lung diseases: friend or foe.Integrated analysis identifies interaction patterns between small molecules and pathwaysCancer and inflammation: promise for biologic therapy.HMGB1 in health and disease.RAGE signaling significantly impacts tumorigenesis and hepatic tumor growth in murine models of colorectal carcinoma.Ethyl pyruvate inhibits HMGB1 phosphorylation and release by chelating calciumImmunotherapeutic suppression of indoleamine 2,3-dioxygenase and tumor growth with ethyl pyruvate.HMGB1 is a therapeutic target for sterile inflammation and infection.Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regression.HMGB1 in cancer: good, bad, or both?Emerging role of high-mobility group box 1 (HMGB1) in liver diseases.Radiation countermeasure agents: an update.The role of high mobility group box 1 (HMGB1) in colorectal cancer.High-mobility group box 1, oxidative stress, and disease.HMGB1 in hormone-related cancer: a potential therapeutic target.High mobility group box 1 promotes tumor cell migration through epigenetic silencing of semaphorin 3A.Ethyl pyruvate administration suppresses growth and invasion of gallbladder cancer cells via downregulation of HMGB1-RAGE axis.Ethyl pyruvate prevents methyglyoxal-induced retinal vascular injury in rats.HMGB1: A Promising Therapeutic Target for Prostate Cancer.Pyruvate: immunonutritional effects on neutrophil intracellular amino or alpha-keto acid profiles and reactive oxygen species production.Ethyl pyruvate inhibits oxidation of LDL in vitro and attenuates oxLDL toxicity in EA.hy926 cells.Tumor-derived high-mobility group box 1 and thymic stromal lymphopoietin are involved in modulating dendritic cells to activate T regulatory cells in a mouse model.An Innovative Approach for The Integration of Proteomics and Metabolomics Data In Severe Septic Shock Patients Stratified for Mortality.HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells.
P2860
Q27015835-3031337A-FB93-4B92-BD51-48ED2610A9DCQ28068263-118316EF-34AB-479C-8F5F-13DEE82328F2Q28553790-FC6C6C1B-4C60-4216-9B05-297D5A219F63Q33618428-DA3B3EAE-56E4-40EA-B8AC-B7CDB55CCD75Q33638306-BADAA1E5-14A7-4262-BA5A-5F5ED7FF95B7Q33684145-3508C09A-550E-400D-A657-18C2324CD9BEQ33999789-A7597B35-D681-424B-9191-B07CB34C79F5Q34139732-A278FA9C-6EBA-4C5B-BC95-D3179D73F1EEQ34622835-17B9AE82-EC71-41FA-BBFA-EEF5B0306762Q35102969-93687BA1-1932-4260-B789-94529A6A344FQ35192838-DDE57115-DF60-4A65-BD6F-4DF6392D3FE0Q35223589-6794E09E-236A-4CB4-96E6-30B86791CA0FQ35953553-A50F0472-38BA-4087-B3BB-BAE73D644B1CQ36157982-C593A552-16A6-4E2B-A63D-A4C6A9933850Q37067481-1FD0F1C6-87C1-4BE8-9AD5-1C217468024CQ37446034-3273AACF-1CF1-41A0-A1DC-5537DD1C39B3Q37658857-A270655B-EE54-40F2-9D07-2450AC84DDCFQ37685447-56730C54-7384-4BCD-ADA0-350FEF8309B0Q37802381-838E8933-3948-4AD6-8165-81B578F60637Q38203471-21224948-0CCC-4936-8399-FCD69191389AQ39064881-13DC993A-6567-4B81-BB56-B8D174C8704DQ39214419-AEE6299A-E08D-4B68-AE2F-420DB7D21C28Q40509411-BB6393C2-83AF-40A1-9FD7-4A5BFD1DCC48Q41136849-C479B20E-8C06-4024-B86A-7BEAA76D419EQ41974024-6A8993C1-4D4F-4E2A-80E6-25B2B26890ABQ48043781-EF659E87-0B63-42D3-9AC8-26693A016FCCQ50109080-7129D490-C0D9-48DE-9726-F9211504B5ECQ53821170-32E726FD-046A-4FB1-B8B5-A83D8B5BA600Q54645430-52214EAC-EE52-41D6-B8A8-879C35F1C472
P2860
Ethyl pyruvate administration inhibits hepatic tumor growth.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Ethyl pyruvate administration inhibits hepatic tumor growth.
@en
Ethyl pyruvate administration inhibits hepatic tumor growth.
@nl
type
label
Ethyl pyruvate administration inhibits hepatic tumor growth.
@en
Ethyl pyruvate administration inhibits hepatic tumor growth.
@nl
prefLabel
Ethyl pyruvate administration inhibits hepatic tumor growth.
@en
Ethyl pyruvate administration inhibits hepatic tumor growth.
@nl
P2093
P2860
P356
P1476
Ethyl pyruvate administration inhibits hepatic tumor growth.
@en
P2093
Antonio Romo de Vivar Chavez
Donna Beer-Stolz
Herbert J Zeh
Michael E de Vera
Michael T Lotze
Nicole E Schapiro
Patricia Loughran
Stephen H Thorne
Xiaoyan Liang
P2860
P304
P356
10.1189/JLB.0908578
P577
2009-09-01T00:00:00Z